Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research
Ralf Illing/LinkedIn
Apr 12, 2026, 15:54

Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research

Ralf Illing, Program and Solution Manager, Data and Systems Integration, STO at GE Healthcare, shared on LinkedIn about a recent article he contributed to, adding:

”Proud to share that I contributed as a patient author to a peer-reviewed publication in Future Neurology:

‘Plain language summary of publication of the OCEANIC-STROKE Phase 3 study design: evaluating asundexian for preventing secondary strokes’
Sharma, Illing et al. | Future Neurology, 21(1), 2026

OCEANIC-STROKE is a global Phase 3 clinical trial involving approximately 12,300 participants across 37 countries, investigating whether asundexian – an oral Factor XIa inhibitor – can reduce the risk of secondary stroke when added to standard antiplatelet therapy, with minimal impact on bleeding risk.

As a stroke survivor myself, I was invited to co-author this plain language summary – a format designed to make complex clinical research accessible to patients, caregivers, and non-specialist healthcare providers.

Why does this matter?
Clinical trials generate critical evidence. But that evidence only creates real-world impact when patients and their families can actually understand it.

Plain language summaries bridge that gap – and patient authors help ensure the language truly reflects lived experience.

I believe that meaningful patient involvement in research – not just as participants, but as contributors and communicators – is essential for advancing patient-centered medicine.

The full results of OCEANIC-STROKE are yet to be published.

I look forward to seeing what they mean for the stroke community.”

Title: Plain language summary of publication of the OCEANIC-STROKE Phase 3 study design: evaluating asundexian for preventing secondary strokes

Authors: Mukul Sharma, Ralf Illing, Pablo Colorado, Jennifer Gilbride, Lars Keller, Eva Muehlhofer, Ashkan Shoamanesh

Read the Full Article on Future Neurology

Ralf Illing: Proud to Contribute My Patient Voice to OCEANIC-STROKE Research

Stay updated on all scientific advances with Hemostasis Today.

Ashkan Shoamanesh Eva Muehlhofer Factor XI Future Neurology Health Hematology Hemostasis Hemostasis News Hemostasis Today Jennifer Gilbride Lars Keller Medicine Mukul Sharma OCEANIC-STROKE Pablo Colorado Ralf Illing research stroke thrombosis
NewsFeed